BIOA
Price:
$18.04
Market Cap:
$679.20M
BioAge Labs, Inc. is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing therapeutic solutions for metabolic illnesses. The company employs a distinctive technology platform alongside specialized human datasets to pinpoint potential drug targets by unraveling the molecular mechanisms underlying the aging process. Their current pipeline features azelaprag, an oral small molecule, which is undergoing Phase 1 clinical trials for obesity. Additionally, BioAge has commenced a Phase 2 clinical trial for azelaprag, investigating its efficacy in combination with tirzepatide for managing obesity specifically in older adults. Another asset under development is BGE-100, an or...[Read more]
Industry
Biotechnology
IPO Date
2024-09-26
Stock Exchange
NASDAQ
Ticker
BIOA
According to BioAge Labs, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -7.52. This represents a change of 74.08% compared to the average of -4.32 of the last 4 quarters.
The mean historical PE Ratio of BioAge Labs, Inc. over the last ten years is -8.59. The current -7.52 PE Ratio has changed 8.65% with respect to the historical average. Over the past ten years (40 quarters), BIOA's PE Ratio was at its highest in in the June 2025 quarter at -1.72. The PE Ratio was at its lowest in in the March 2023 quarter at -14.11.
Average
-8.59
Median
-7.85
Minimum
-15.75
Maximum
-2.92
Discovering the peaks and valleys of BioAge Labs, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 102.04%
Maximum Annual PE Ratio = -2.92
Minimum Annual Increase = -70.23%
Minimum Annual PE Ratio = -15.75
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -5.90 | 102.04% |
| 2024 | -2.92 | -70.23% |
| 2023 | -9.81 | -37.74% |
The current PE Ratio of BioAge Labs, Inc. (BIOA) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-6.21
5-year avg
-8.59
10-year avg
-8.59
BioAge Labs, Inc.’s PE Ratio is less than Lifecore Biomedical, Inc. (-6.20), less than Canopy Growth Corporation (-1.49), less than Allogene Therapeutics, Inc. (-2.63), less than Editas Medicine, Inc. (-2.25), greater than Alpha Teknova, Inc. (-13.11), less than Aurora Cannabis Inc. (-3.25), less than Atea Pharmaceuticals, Inc. (-2.10), less than Owens & Minor, Inc. (-0.24), less than Cabaletta Bio, Inc. (-1.92), less than Humacyte, Inc. (-2.14),
| Company | PE Ratio | Market cap |
|---|---|---|
| -6.20 | $211.55M | |
| -1.49 | $425.84M | |
| -2.63 | $463.35M | |
| -2.25 | $244.75M | |
| -13.11 | $225.18M | |
| -3.25 | $172.40M | |
| -2.10 | $359.32M | |
| -0.24 | $207.07M | |
| -1.92 | $490.79M | |
| -2.14 | $177.24M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioAge Labs, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioAge Labs, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is BioAge Labs, Inc.'s PE Ratio?
How is the PE Ratio calculated for BioAge Labs, Inc. (BIOA)?
What is the highest PE Ratio for BioAge Labs, Inc. (BIOA)?
What is the 3-year average PE Ratio for BioAge Labs, Inc. (BIOA)?
What is the 5-year average PE Ratio for BioAge Labs, Inc. (BIOA)?
How does the current PE Ratio for BioAge Labs, Inc. (BIOA) compare to its historical average?